JOSEPH D KEEGAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH D KEEGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSEPH D KEEGAN. JOSEPH D KEEGAN is in BIO-TECHNE Corp ($TECH) and Director in BIO-TECHNE Corp ($TECH) and CEO/President in MOLECULAR DEVICES CORP ($MDCC) and Director in Interpace Diagnostics Group, Inc. ($PDII) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in Stereotaxis, Inc. ($STXS).
Latest Insider Trading Transactions of JOSEPH D KEEGAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TECH, IDXG, MDCC, RPBIF, STXS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 02 2020 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Option Exercise | A | 255.69 | 1,507 | 385,325 | 1,507 | ||
| Nov 02 2020 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Grant | A | 0.00 | 391 | 0 | 2,139 | 1.7 K to 2.1 K (+22.37 %) | |
| Jul 10 2020 | IDXG | INTERPACE BIOSCIEN ... | KEEGAN JOSEPH D | Director | Option Exercise | A | 5.21 | 29,000 | 151,090 | 29,000 | |
| Jul 10 2020 | IDXG | INTERPACE BIOSCIEN ... | KEEGAN JOSEPH D | Director | Option Exercise | A | 5.21 | 29,000 | 151,090 | 29,000 | |
| Oct 28 2019 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 | |
| Oct 28 2019 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 495 | 0 | 1,748 | 1.3 K to 1.7 K (+39.51 %) |
| Oct 29 2018 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Option Exercise | A | 179.84 | 1,898 | 341,336 | 1,898 | ||
| Oct 29 2018 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Grant | A | 0.00 | 514 | 0 | 1,253 | 739 to 1.3 K (+69.55 %) | |
| Mar 09 2018 | IDXG | Interpace Diagnost ... | KEEGAN JOSEPH D | Director | Option Exercise | A | 1.01 | 19,200 | 19,392 | 19,200 | |
| Mar 09 2018 | IDXG | Interpace Diagnost ... | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 4,800 | 0 | 17,569 | 12.8 K to 17.6 K (+37.59 %) |
| Oct 31 2017 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Option Exercise | A | 125.05 | 3,125 | 390,781 | 3,125 | ||
| Oct 31 2017 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Grant | A | 0.00 | 739 | 0 | 739 | 0 to 739 | |
| Sep 26 2017 | IDXG | Interpace Diagnost ... | KEEGAN JOSEPH D | Director | Option Exercise | A | 1.48 | 10,000 | 14,800 | 10,000 | |
| Dec 01 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Option Exercise | D | 0.85 | 5,000 | 4,250 | 0 | |
| Dec 01 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Option Exercise | D | 0.92 | 5,000 | 4,600 | 0 | |
| Dec 01 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Option Exercise | D | 1.43 | 5,000 | 7,150 | 0 | |
| Dec 01 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Option Exercise | D | 3.10 | 20,000 | 62,000 | 0 | |
| Dec 01 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Option Exercise | D | 2.20 | 20,000 | 44,000 | 0 | |
| Dec 01 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Sell | D | 0.00 | 73,850 | 0 | 0 | 73.9 K to 0 (-100.00 %) |
| May 25 2016 | STXS | Stereotaxis, Inc. | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 10,000 | 0 | 51,593 | 41.6 K to 51.6 K (+24.04 %) |
| Mar 28 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Option Exercise | A | 0.85 | 5,000 | 4,250 | 5,000 | |
| Mar 28 2016 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 27,941 | 0 | 73,850 | 45.9 K to 73.9 K (+60.86 %) |
| Feb 05 2016 | PDII | Interpace Diagnost ... | KEEGAN JOSEPH D | Director | Grant | A | 0.47 | 127,696 | 60,017 | 127,696 | 0 to 127.7 K |
| Jun 03 2015 | STXS | Stereotaxis, Inc. | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 10,000 | 0 | 41,593 | 31.6 K to 41.6 K (+31.65 %) |
| May 21 2015 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 7,291 | 0 | 45,909 | 38.6 K to 45.9 K (+18.88 %) |
| Mar 23 2015 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Option Exercise | A | 0.92 | 5,000 | 4,600 | 5,000 | |
| Mar 23 2015 | RPBIF | RESPONSE BIOMEDICA ... | KEEGAN JOSEPH D | Director | Grant | A | 0.00 | 6,250 | 0 | 38,618 | 32.4 K to 38.6 K (+19.31 %) |
| Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | A | 19.66 | 60,000 | 1,179,600 | 60,000 | |
| Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 14.32 | 273 | 3,909 | 852 | 579 to 852 (+47.15 %) |
| Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 14.32 | 272 | 3,895 | 579 | 307 to 579 (+88.60 %) |
Page: 1